Barth, Rolf F.
The Ohio State University,
United States
2025 Rank: 105364
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3204 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 105364 | 118891 |
| Total Cites | 406 | 424 |
| H-index | 8 | 8 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 94 | 94 |
| Total Cites to Single+First Authored Papers | 242 | 249 |
| Number of Single+First+Last Authored Papers | 130 | 130 |
| Total Cites to Single+First+Last Authored Papers | 247 | 255 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 248 | 253 |
| Ratio of Total Citations to Distinct Citing Papers | 1.64 | 1.68 |
| Self-Citation Percentage |
4.25%
|
|
Barth, Rolf F.
The Ohio State University,
United States
2024 Rank: 64878
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2102 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64878 | 74740 |
| Total Cites | 463 | 471 |
| H-index | 9 | 9 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 14 | 14 |
| Number of Single+First Authored Papers | 93 | 93 |
| Total Cites to Single+First Authored Papers | 260 | 266 |
| Number of Single+First+Last Authored Papers | 129 | 129 |
| Total Cites to Single+First+Last Authored Papers | 267 | 274 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 279 | 280 |
| Ratio of Total Citations to Distinct Citing Papers | 1.66 | 1.68 |
| Self-Citation Percentage |
1.70%
|
|
Barth, Rolf F.
The Ohio State University,
United States
2023 Rank: 79726
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 2892 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 79726 | 85751 |
| Total Cites | 487 | 517 |
| H-index | 9 | 9 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 94 | 94 |
| Total Cites to Single+First Authored Papers | 269 | 277 |
| Number of Single+First+Last Authored Papers | 130 | 130 |
| Total Cites to Single+First+Last Authored Papers | 281 | 292 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 291 | 299 |
| Ratio of Total Citations to Distinct Citing Papers | 1.67 | 1.73 |
| Self-Citation Percentage |
5.80%
|
|
Barth, Rolf F.
The Ohio State University,
United States
2022 Rank: 48013
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1825 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 48013 | 55075 |
| Total Cites | 548 | 571 |
| H-index | 10 | 10 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 13 | 13 |
| Number of Single+First Authored Papers | 94 | 94 |
| Total Cites to Single+First Authored Papers | 304 | 316 |
| Number of Single+First+Last Authored Papers | 130 | 130 |
| Total Cites to Single+First+Last Authored Papers | 312 | 325 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 335 | 344 |
| Ratio of Total Citations to Distinct Citing Papers | 1.64 | 1.66 |
| Self-Citation Percentage |
4.03%
|
|
Barth, Rolf F.
The Ohio State University,
United States
2021 Rank: 42108
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1526 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 42108 | 44989 |
| Total Cites | 827 | 892 |
| H-index | 12 | 13 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 28 | 28 |
| Number of Single+First Authored Papers | 92 | 92 |
| Total Cites to Single+First Authored Papers | 469 | 492 |
| Number of Single+First+Last Authored Papers | 128 | 128 |
| Total Cites to Single+First+Last Authored Papers | 483 | 508 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 479 | 495 |
| Ratio of Total Citations to Distinct Citing Papers | 1.73 | 1.80 |
| Self-Citation Percentage |
7.29%
|
|
Barth, Rolf F.
The Ohio State University,
United States
2020 Rank: 57924
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 2018 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 57924 | 61258 |
| Total Cites | 594 | 625 |
| H-index | 9 | 10 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 6 | 6 |
| Total Cites to Single Authored Papers | 19 | 19 |
| Number of Single+First Authored Papers | 89 | 89 |
| Total Cites to Single+First Authored Papers | 325 | 344 |
| Number of Single+First+Last Authored Papers | 124 | 124 |
| Total Cites to Single+First+Last Authored Papers | 338 | 358 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 328 | 337 |
| Ratio of Total Citations to Distinct Citing Papers | 1.81 | 1.85 |
| Self-Citation Percentage |
4.96%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.